Issue link: https://beckershealthcare.uberflip.com/i/1446606
37 QUALITY IMPROVEMENT & MEASUREMENT Mortality rates dropped 33% at NYC hospital after NYU Langone merger: study By Marissa Plescia I n-hospital mortality rates decreased by 33 percent at New York City-based NYU Langone Hospital-Brooklyn — pre- viously named Lutheran Medical Center — aer it merged with NYU Langone Health, a Jan. 6 study published in JAMA Network Open found. NYU Langone Health acquired the hospital in 2016. e study analyzed outcomes for 181,252 nonpsychiatric, nonrehabili- tation and non-newborn patients discharged between Sept. 1, 2010, and Aug. 31, 2019, at the hospital. e study found fewer central infections per 1,000 catheter days and fewer catheter-associated urinary tract infections per 1,000 discharges. More patients were likely to recommend the hospital aer the merger than before. e study did not find any significant improvements in readmis- sion rates. "Our study shows that when a hospital merger has a compre- hensive strategy, focuses on quality and involves meaningful operational integration, outcomes can be significantly improved at the acquired hospital," lead study author Erwin Wang, MD, said in Jan. 6 news release by NYU Langone Health. n High-flow oxygen cuts need for ventilator use among COVID-19 patients, study finds By Erica Carbajal A mong hospitalized COVID-19 patients, the use of high- flow oxygen through a nasal cannula reduced the need for invasive mechanical ventilation and sped up recovery compared to conventional oxygen therapy, according to research published Dec. 7 in the Journal of the American Medical Associ- ation. Researchers analyzed the outcomes of 199 COVID-19 patients in the emergency and intensive care units across three Colum- bian hospitals from August 2020 to January 2021 and followed them through Feb. 10, 2021. About half were given high-flow oxygen and half were assigned conventional oxygen therapy. About 34.3 percent of patients receiving high-flow oxygen were intubated, compared to 51 percent of those on conven- tional oxygen therapy. The median time to recover among the high-flow oxygen cohort was lower at 11 days compared to 14 days for patients receiving conventional oxygen therapy. "Among patients with severe COVID-19, use of high-flow oxygen through a nasal cannula significantly decreased need for mechanical ventilation support and time to clinical recov- ery compared with conventional low-flow oxygen therapy," researchers concluded. n 12TH ANNUAL MEETING April 25-28, 2022 // Hyatt Regency, Chicago